Baseline comparisons of adiponectin, resistin, and BDNF concentrations were not significantly different before and after ECT treatment in the entire patient group and subgroups distinguished by depression type, sex, or symptom improvement status. This evidence concerns the gene BDNF and depressive symptom measurement.